- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 94 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- January 2024
- 89 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- November 2022
- 83 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Book
- October 2019
- 720 Pages
Colistin is an antibiotic used to treat serious bacterial infections, particularly those caused by Gram-negative bacteria. It is a polymyxin, a type of polypeptide antibiotic derived from the bacterium Paenibacillus polymyxa. Colistin is used in combination with other antibiotics to treat infections that are resistant to other antibiotics. It is also used to prevent infections in patients who are at high risk of developing them.
Colistin is available in both oral and injectable forms. It is typically used in combination with other antibiotics, such as aminoglycosides, cephalosporins, and carbapenems. The use of colistin has increased in recent years due to the emergence of antibiotic-resistant bacteria.
Colistin is produced by several pharmaceutical companies, including Pfizer, Merck, Sanofi, and AstraZeneca. It is also available as a generic drug from several generic drug manufacturers.
In conclusion, Colistin is an important antibiotic used to treat serious bacterial infections, particularly those caused by Gram-negative bacteria. It is available in both oral and injectable forms and is produced by several pharmaceutical companies, including Pfizer, Merck, Sanofi, and AstraZeneca. Show Less Read more